Hear from our Co-founder, Krisha Patel, and CEO of Cellular Origins, Edwin Stone as they discuss the current challenges in building infrastructure and capacity for cell and gene therapy in this panel hosted by Carol Houts, CSO at Germfree. 📹 📢
🔹 The use of automation tools and robotic solutions that support scale-up activities. Technologies that particularly focus on reducing space required for manufacturing and reduction of manual interventions.
🔹Leveraging existing regulatory frameworks to establish quality systems for decentralized manufacturing, mobile units, and point of care.
🔹Use of technologies for standardizing data collection from electronic health records to distribution of therapies.